Skip to content
Pharmaron
  • 中文
  • Locations
  • Services
    • Laboratory Services
      • Laboratory Chemistry
        • Synthetic Chemistry
          • Heterocycles
          • Library Synthesis
          • Protein Degraders
          • Carbohydrates
          • Peptide Synthesis
          • Nucleosides / Nucleotides
        • Medicinal Chemistry
        • Chemistry for New Modalities
          • Nucleosides / Nucleotides
          • Lipids
          • Antibody-drug Conjugates
        • Radiolabelling & Radiosynthesis
        • Computer-Aided Drug Design
        • Analytical and Purification Sciences
        • DNA-Encoded Libraries
        • Cheminformatics
        • Enabling Technology
      • Structural Biology
      • in vitro Biology
        • Target Identification and Validation
        • Kinase Profiling            
        • Biochemistry
        • Biophysics
        • Cell Line Engineering
        • Cell Biology
        • Cellular Disease Models
        • In Vitro Toxicity Testing
      • in vivo Pharmacology
        • Oncology Models
        • Cardiovascular and Metabolic Diseases
        • Inflammation and Pain Models
        • CNS Disease Animal Models
        • Dermal Models
        • Ocular Models
        • Medical Devices Animal Models
      • DMPK
        • Discovery in vitro ADMET
        • Discovery in vivo PK
        • Regulatory in vivo PK
        • Regulatory in vitro ADMET
        • Radiolabelled Metabolism and Biodistribution
        • Integrated in vitro and in vivo ADME
      • Safety Assessment
        • Regulatory In Vitro Toxicology
        • General Toxicology
        • Safety Pharmacology
        • Genetic Toxicology
        • Developmental and Reproductive Toxicology
        • Pathology
        • Specialty Safety Assessment
        • Bioanalysis Services
      • Bioanalysis
        • Small Molecule Bioanalysis
        • Large Molecule Bioanalysis
        • CGT Bioanalysis
        • Carbon-14 Bioanalysis
        • Biomarker Assays
      • Integrated Drug Discovery
      • Medical Device Testing
    • Chemistry, Manufacturing & Controls
      • Small Molecule Drug Substance
        • Discovery Process Chemistry
        • Process Chemistry
          • Enabling Technology
        • Analytical Development and Quality Control
        • Material Science
        • Process Safety and Engineering
        • API Manufacturing
        • Flow Chemistry
      • Small Molecule Drug Product
        • Formulation Development
        • Analytical Development and Quality Control
        • Drug Product Manufacturing
      • Clinical and Commercial Late-Stage Manufacturing CDMO
      • Quality Assurance
      • Regulatory Affairs
    • Clinical Development
      • Integrated Radiolabelled Sciences
        • Radiolabelling and Radiosynthesis
          • Carbon-14 Radiosynthesis
          • Tritium Radiosynthesis
          • GMP Carbon-14 Radiolabelled APIs and IMPs
          • Tritium and Carbon-14 Radiolabels (RadioTag)
        • Non-clinical ADME with Radiolabelled Compounds
          • Radiolabelled in vitro Metabolism Studies
          • in vivo PK Using Radiolabelled Compounds
          • Tissue Distribution with QWBA and mARG
        • Human AME with Radiolabelled Compounds
          • Pharmacokinetics with Radiolabelled Compounds
          • Mass Balance with Radiolabelled Compounds
          • Metabolite Profiling of Radiolabelled Compounds
          • Metabolite Identification with HRMS
          • Drug-drug Interaction (DDI) Studies
        • Disposition of Radiolabelled Biologics
          • Tritium and Carbon-14 Radiolabels (RadioTag)
          • AMS and Carbon-14 Radiolabelled Biologics
        • Accelerator Mass Spectrometry (AMS)
          • Carbon-14 Microtracers
          • Ultra-sensitive AMS
          • Accelerated Carbon-14 Clinical Programs
          • Phase 0 Microdosing
          • Absolute Bioavailability and IV Pharmacokinetics
          • Mass Balance by AMS
          • Metabolite Profiling Using AMS
          • AMS for Carbon-14 Non-clinical Studies
          • Carbon-14 Radiolabels and AMS for Biologics
        • Environmental Metabolism
          • Dermal Penetration Studies
          • Plant and Livestock Metabolism
      • Clinical Development (US)
        • Early Phase Clinical Research
        • 14C Radiolabelled Studies – Human ADME (Macrotracer/Microtracer)
        • Vaccine Development and Infectious Challenge Studies
        • Accelerator Mass Spectrometry
        • Bioanalysis
        • Biometrics
      • Clinical Development (China)
      • Regulatory Affairs
      • Clinical Trial Recruitment
        • Clinical Trial Recruitment (US)
    • Biologics
      • Biologics Laboratory Services
        • Antibody Discovery
        • Protein Science
        • Biologics PK
        • Safety Assessment
        • Large Molecule Bioanalysis
      • Biologics CDMO
        • IND-Enabling Services
        • Developability Assessment
        • Cell Line Development
        • Process Development Solutions
        • Drug Product Development
        • Analytical Services
        • Drug Substance Manufacturing
        • Drug Product Manufacturing
        • Quality
    • Cell and Gene Therapy
      • Preclinical Studies
        • CGT in vivo Pharmacology
        • CGT Safety Assessment
        • CGT Ophthalmology
      • CGT Bioanalysis
        • Biodistribution and Viral Shedding
        • Immunogenicity Assays
        • Biomarker Assays
      • Analytical Testing Services
        • Cell-Based Potency Assays
        • Enhance Drug Efficacy with Cell-Based Assays
        • GMP Analytical Platforms
        • Cell-Based Potency Assay FAQs
      • Gene Therapy CDMO
        • GMP Plasmid DNA Manufacturing
        • Viral Vector Process Development
        • Product Characterization and QC Analytics
        • GMP Gene Therapy Manufacturing
        • Regulatory Dossier Authoring & Specification Justification
  • Modalities
    • Small Molecules
    • Biologics
    • Cell and Gene Therapies
    • ADC & other Bioconjugates
    • Protein Degraders
  • Stories
  • Knowledge Center
    • Symposiums
    • Chemistry Lecture Series
    • Publications
    • Posters
    • Webinars
    • Podcasts
    • Brochures and Service Overviews
  • About Us
    • Overview
    • Leadership
    • Culture
    • Sustainability (ESG)
    • Locations
    • Upcoming Events
    • Latest News
  • Careers
    • Working at Pharmaron
    • Employee Testimonials
    • Job Openings
  • Investors
  • Contact

Home - Knowledge Center - Morpholine Synthesis via Grignard and N‑Sulfinyl Imines

Diastereoselective Synthesis of Morpholine Derivatives from Grignard Reagents and N-Sulfinyl Imines

Publication banner featuring an article on diastereoselective synthesis of morpholine derivatives from Grignard reagents and N‑sulfinyl imines, with a Pharmaron branding

Capabilities

Knowledge Center
Laboratory Chemistry
Connect with a Scientific Expert

Authors: Joseph M. Bateman, Diana Chan, Mustafa Moroglu, Benjamin F. Rahemtulla, Eric P. A. Talbot

ACS Omega. 2023 Jun 19;8(26):24072-24077

DOI: 10.1055/a-1529-4797

  • Services
    • Laboratory Services
    • Chemistry, Manufacturing & Controls
    • Clinical Development
    • Biologics
  • Knowledge Center
    • Symposiums
    • Chemistry Lecture Series
    • Publications
    • Posters
    • Webinars
    • Podcasts
    • Brochures and Service Overviews
  • About Us
    • Overview
    • Leadership
    • Culture
    • Sustainability (ESG)
    • Locations
    • Latest News
  • Modalities
  • Stories
  • Careers
  • Investors
  • Connect with our Scientific Experts
  • LinkedIn
  • Twitter
  • Instagram
  • Send an Email
© Pharmaron, 2026. All Rights Reserved
  • Privacy Policy
  • Site Map
  • Code of Conduct
  • Code of Conduct for Business Partners
  • Modern Slavery Act Statement 2025
  • Data Subject Access Rights

Pharmaron is a contract research and manufacturing organization (CRO/CDMO) providing services to pharmaceutical, biotech, and medical device companies. This website is intended for professional and institutional use only. We do not offer or advertise medical treatments, therapies, or drugs to the public. All services are limited to research, development, regulatory collaboration and commercial manufacturing with life science organizations.